No spam - just the good stuff

Subscribe to our newsletter

News

AI

At-home diagnostic system sees growth in older users

AI fast-tracks human longevity extension

Skin data innovator announces residency at JLABS @ Shanghai

Following the international expansion in South Korea, Vietnam and Indonesia, HautAI skin aging tech now enters the Chinese market.

Longevity Escape Velocity within 10 years?

AI to quantify senescent cell counts

Longevity companies to watch in 2021

A year in Longevity: progress perspectives

A year in Longevity: different perspectives

A year in Longevity: science perspectives

Loop Insights launches platform to connect healthcare systems

GrimAge clock – it’s all a matter of time

First human AI-powered psychological aging clock published

Regent Pacific completes acquisition of Deep Longevity

Press one for employee happiness and Longevity

Smart tech earring is CGM game-changer

Deep Longevity reveals highly-accurate aging clock

BioAge lands $90 million; gears up for clinical trials in 2021

Neurotech2020 – a clear head for neurotech, research and investment

Wearables and AI on the frontline of Longevity

Bridging the gap between Longevity science and clinicians

Start-up Sentai wins UK independent living grant

Tina Woods: Prevention is vital for Longevity

Wearable firm switches focus to enterprise

AgeCurve app rolls out Longevity strategy content

Atlas Biomed set to be big in Japan

Brain-inspired AI targets neurodegenerative breakthroughs

Up-skilling clinicians in AI-guided Longevity medicine

Profiling and understanding plasma proteomes could unlock Longevity

Healthspan wearables and subscription services are hot!

WHO portal brings aging data together

Deep Longevity and Longenesis collaborate to clock aging

Big Brother approach to accelerate preclinical studies

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.